Damla Demir

Damla Demir

Auto-generated profile, based on publicly available information

Damla Demir

Department of Dermatology Health Science University Ümraniye Training and Research Hospital Istanbul Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Annals of Dermatology
Verified
Journal Article
Open access
EKEzgi Aktaş Karabay
Ezgi Aktaş Karabay
AÇAslı Aksu Çerman
Aslı Aksu Çerman
DDDamla Demir
Damla Demir
IAIlknur Kıvanç Altunay
Ilknur Kıvanç Altunay
Currently, no generally accepted laboratory marker for monitorizing the disease activity and therapy response of psoriasis is known. The aim of the study is to evaluate the effects of systemic therapies on C-reactive protein (CRP) and the neutrophil-lymphocyte ratio (NLR) in psoriasis. One hundred patients with psoriasis treated with narrow band ultraviolet B, acitretin, cyclosporine, methotrexate, adalimumab, etanercept, and ustekinumab were prospectively evaluated. At baseline and at week 12, CRP, NLR, and Psoriasis Area and Severity Index (PASI) were evaluated. A statistically significant decrease was observed in PASI scores, CRP, and NLR values from the baseline to the 12-week visit (p=0.001, p=0.001, p=0.001, respectively). The reduction in PASI scores and NLR values was positively correlated (r=0.460, p=0.001). The comparisons between treatment groups revealed that the median decrease in NLR values was statistically higher in the adalimumab group than in the methotrexate group (p=0.007). And the median decrease in PASI scores was significantly higher in the adalimumab group compared with the methotrexate and acitretin therapy group (p=0.007, p=0.042, respectively). In the present study, systemic therapy of psoriasis was demonstrated to decrease the levels of CRP and NLR, which are known to be indicators of systemic inflammation and cardiovascular comorbidities.

1 January 2020 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
EKEzgi Aktaş Karabay
Ezgi Aktaş Karabay
DDDamla Demir
Damla Demir
AÇAslı Aksu Çerman
Aslı Aksu Çerman
Psoriasis is a chronic immune-mediated inflammatory skin disease that is associated with cardiovascular comorbidities. The objective of this retrospective study is to assess the C-reactive protein, monocyte-to-high-density-lipoprotein ratio, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio as inflammatory markers in patients with psoriasis and to search for a relationship between these parameters and psoriasis severity, as defined by the psoriasis area and severity index. There were 94 patients with psoriasis and 118 healthy controls enrolled in the study. The C-reactive protein, monocyte-to-high-density-lipoprotein ratio, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio values of two groups were retrospectively evaluated. Statistically significant differences were observed in terms of C-reactive protein, monocyte-to-high-density-lipoprotein ratio, neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio between the patient and control groups (p=0.001, p=0.003, p=0.038, and p=0.007, respectively). Positive correlations were found between the psoriasis area and severity index and the values of C-reactive protein, monocyte-to-high-density-lipoprotein ratio, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio (r: 0.381; p<0.01, r: 0.203; p<0.05, r: 0.268; p<0.01, r: 0.374; p<0.01, r: 0.294; p<0.01, respectively). The small sample size and the retrospective design of the study are limitations. Elevated C-reactive protein, monocyte-to-high-density-lipoprotein ratio, neutrophil-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio were significantly associated with psoriasis. A positive correlation between C-reactive protein and monocyte-to-high-density-lipoprotein ratio leads to the suggestion that monocyte-to-high-density-lipoprotein ratio might be a reliable parameter in psoriasis during the follow-up. The relationship between the diasease and inflammatory parameters might provide early detection of cardiovascular morbidities in psoriasis patients.

1 November 2020 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
EÖEzgi Özkur
Ezgi Özkur
YEYasemin Erdem
Yasemin Erdem
IAİlKnur Kıvanç Altunay
İlKnur Kıvanç Altunay
DDDamla Demir
Damla Demir
NDNurcihan Çalışkan Dolu
Nurcihan Çalışkan Dolu
AÇAslı Aksu Çerman
Aslı Aksu Çerman
Hidradenitis suppurativa is a chronic inflammatory skin disease of terminal follicular acroinfundibulum. This study aimed to evaluate serum irisin, plasma glucose, insulin, and lipid levels in hidradenitis suppurativa, and elucidate possible associations with disease activity, inflammatory, or metabolic parameters. This case-control study included 37 patients (M/F: 9/28) and 37 sex-, age- and body mass index -matched healthy controls (M/F: 11/26). Demographic data, Hurley stage of disease, fasting glucose, insulin, total cholesterol, high density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, C-reactive protein levels, erythrocyte sedimentation rate, hematologic parameters, and serum irisin were assessed. The hidradenitis suppurativa group had significantly higher waist circumference than controls (p<0.001). Insulin resistance, defined as a homeostatic model assessment for insulin resistance value greater than 2.5, was observed in 45.9% of patients and 8.1% of controls (p=0.003), whereas metabolic syndrome was observed in 32.4% of patients and 5.4% of controls (p<0.001). Furthermore, plasma triglycerids, glucose, and insulin levels were significantly higher in the hidradenitis suppurativa (p=0.013, p=0.001, and p=0.004), respectively. Mean irisin level was insignificantly higher in the hidradenitis suppurativa group (37.4±32.6) than in controls (26.2±24.7, p=0.217). Physical activity and the exercise levels of participants were not documented. This study indicates that hidradenitis suppurativa patients have higher serum irisin, fasting plasma glucose, insulin, and triglycerides levels than healthy controls. Thus, the authors suggest that hidradenitis suppurativa patients should be evaluated for insulin resistance and metabolic syndrome, and monitored accordingly.

6 January 2021 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
EKEzgi Aktaş Karabay
Ezgi Aktaş Karabay
DDDamla Demir
Damla Demir
FGFatıma Gürsoy
Fatıma Gürsoy
İZİlkin Zindancı
İlkin Zindancı

14 December 2020 in Journal of the Turkish Academy of Dermatology
Verified
Journal Article
Closed access
DDDamla Demir
Damla Demir
EEErhan Ersoy
Erhan Ersoy
İZİlkin Zindancı
İlkin Zindancı

1 November 2020 in Anais Brasileiros de Dermatologia (Versão em Português)
Verified
Journal Article
Open access
EÖEzgi Özkur
Ezgi Özkur
YEYasemin Erdem
Yasemin Erdem
IAİlknur Kıvanç Altunay
İlknur Kıvanç Altunay
DDDamla Demir
Damla Demir
NDNurcihan Çalışkan Dolu
Nurcihan Çalışkan Dolu
AÇAslı Aksu Çerman
Aslı Aksu Çerman